FILED UNDER SOMETHINGISRAELI >> Health & Lifestyle
Israel's office of the Chief Scientist has awarded a $1.3m grant to Rehovat based Pharmos corporation to develop new drugs that can help relieve pain from patients.
The grant will support work being conducted by the company both inside Israel and also outside the country.
Earlier this year, Pharmos reported great success with a new drug, cannabinor that has been around for many years, but has not fully developed. It works by targeting the cannabinoid receptors that are located in the brain as well as the liver and kidney and can provide relief from pain.
Later this year, the company plans to extend its trials by offering cannabinor in patients experiencing pain after molar extraction dental treatment.
While based on the cannabis plant, cannabinor is developed in the laboratory based on synthetic chemicals that are actually more powerful than the natural substance.
The company also claims that, while many patients are treated with drugs to combat pain, much of this is based on opioids which can cause side effects including addiction and constipation. Cannabinor is said to be able to produce equally successful results without the side effects.
As well as dental pain, the plan is for cannabinor development to cover other pain related ailments including cancer, lower back and neuropathic.
For more information: www.pharmoscorp.com